Ali I, Mukhtar SD, Ali HS, Scotti MT, Scotti L. Advances in nanoparticles as anticancer drug delivery vector: need of this century. Curr Pharm Des 2020; 26(15): 1637-49.
Lather A, Sharma S, Khatkar S, Khatkar A. Docking related survey on heterocyclic compounds based on glucosamine-6-phosphate synthase inhibitors and their antimicrobial potential. Curr Pharm Des 2020; 26(15): 1650-65.
Roy H, Nayak BS, Nandi S. Chitosan anchored nanoparticles in current drug development utilizing computer-aided pharmacokinetic modeling: case studies for target specific cancer treatment and future prospective. Curr Pharm Des 2020; 26(15): 1666-75.
Gul S, Khalil R, Ul-Haq Z, Mubarak MS. Computational overview of mycobacterial thymidine monophosphate kinase. Curr Pharm Des 2020; 26(15): 1676-81.
Monteiro KLC, Alcantara MGS, Aquino TM, Silva-Jr EF. Tau protein aggregation in alzheimer’s disease: recent advances in the development of novel therapeutic agents. Curr Pharm Des 2020; 26(15): 1682-92.
Alachkar A, Ojha SK, Sadeq A, et al. Experimental models for discovery of novel anticonvulsant drugs: focus on pentylenetetrazole-induced seizures and associated memory deficits. Curr Pharm Des 2020; 26(15): 1693-711.